Tuesday, September 16, 2025 12:57:32 PM
Hey bud, you have the wiser strategy and my holdings and average are much more the function of luck than investment savvy. I am very fortunate and I am as frustrated as anyone, but the Advent news to me created the anomaly/arbitrage opportunity of a lifetime.
Only those that truly understand LP from decades of excruciating silence in the face of endless delays, dilution, manipulation, while simultaneously getting rich off of building up and selling cognate to CRL, KNOWS deep down that she wouldn't sell Advent to NWBO for pennies on the dollar nearly 2 years after filing the MAA for DCVAX as some sort of empty gesture to shareholders (I know an argument could be made that she did it for liability reasons but I don't buy that either).
LP is a lot of things but she ain't stupid and she loves her money. Losing 50-75 million on advent is chump change if you consider that a buyout for even 20 billion would net LP 2 BILLION DOLLARS.
Only long suffering investors who understand the true value of the DCVAX platform would intuitively know that LP would never release the advent PR NOW if something HUGE wasn't already set in stone IMO.
Only those that truly understand LP from decades of excruciating silence in the face of endless delays, dilution, manipulation, while simultaneously getting rich off of building up and selling cognate to CRL, KNOWS deep down that she wouldn't sell Advent to NWBO for pennies on the dollar nearly 2 years after filing the MAA for DCVAX as some sort of empty gesture to shareholders (I know an argument could be made that she did it for liability reasons but I don't buy that either).
LP is a lot of things but she ain't stupid and she loves her money. Losing 50-75 million on advent is chump change if you consider that a buyout for even 20 billion would net LP 2 BILLION DOLLARS.
Only long suffering investors who understand the true value of the DCVAX platform would intuitively know that LP would never release the advent PR NOW if something HUGE wasn't already set in stone IMO.
Bullish
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
